A open-label, multicentre study to monitor the safety of inhaled zanamivir (as Rotadisk via Diskhaler device) in China.
Phase of Trial: Phase IV
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Zanamivir (Primary)
- Indications Influenza virus infections; Various toxicities
- Focus Adverse reactions
- 23 May 2012 New trial record